Expression and prognostic analyses of the significance of STEAP1 and STEAP2 in lung cancer

Abstract Purpose Lung cancer is the leading cause of cancer-related mortality. STEAP1 and STEAP2 are overexpressed in various cancers. The purpose of this study was to evaluate the expression and prognostic value of STEAP1 and STEAP2 in patients with lung cancer. Methods The mRNA expression and prot...

Full description

Bibliographic Details
Published in:	World Journal of Surgical Oncology
Main Authors:	Tianshu Liu, Xiaoxin Niu, Yanqing Li, Zekun Xu, Jie Chen, Geng Xu
Format:	Article
Language:	English
Published:	BMC 2022-03-01
Subjects:	Lung cancer Patient prognosis Six-transmembrane epithelial antigen of the prostate 1 Six-transmembrane epithelial antigen of the prostate 2 Biomarker
Online Access:	https://doi.org/10.1186/s12957-022-02566-6

Similar Items

Fusion Protein Vaccine Based on Ag85B and STEAP1 Induces a Protective Immune Response against Prostate Cancer
by: Linpei Guo, et al.
Published: (2021-07-01)

Leucine Zipper-EF-Hand Containing Transmembrane Protein 1 Is a Potential Prognostic Biomarker and Promotes Cell Progression in Prostate Cancer
by: Piao L, et al.
Published: (2020-03-01)

STAMP2 increases oxidative stress and is critical for prostate cancer
by: Yang Jin, et al.
Published: (2015-02-01)

The Role of STEAP1 in Prostate Cancer: Implications for Diagnosis and Therapeutic Strategies
by: Lingling Zhang, et al.
Published: (2025-03-01)

Prostate transmembrane androgen inducible protein 1 (PMEPA1): regulation and clinical implications
by: Qicui Zhu, et al.
Published: (2023-12-01)

Targeting TM4SF1 promotes tumor senescence enhancing CD8+ T cell cytotoxic function in hepatocellular carcinoma
by: Weifeng Zeng, et al.
Published: (2025-04-01)

TMEM211 Promotes Tumor Progression and Metastasis in Colon Cancer
by: Yung-Fu Chang, et al.
Published: (2023-05-01)

Nadir prostate-specific antigen as a prognostic factor of 10-year cancer-specific survival of prostate cancer patients with bone metastases
by: Chi-Feng Hung, et al.
Published: (2022-01-01)

Exploring the prognostic significance of STEAP2 and STEAP4 in various subtypes of breast cancer
by: Wenjun Tian, et al.
Published: (2025-04-01)

Benign prostatic hyperplasia and prostate-specific antigen
by: Pejčić Tomislav, et al.
Published: (2015-01-01)

Current biomarkers of prostate cancer
by: I. A. Aboian, et al.
Published: (2021-12-01)

PSA density of the lesion: a mathematical formula that uses clinical and pathological data to predict biochemical recurrence in prostate cancer patients
by: PEDRO HENRIQUE REZENDE JUNQUEIRA, et al.
Published: (2021-10-01)

Immunoinformatic design of a putative multi-epitope vaccine candidate against Trypanosoma brucei gambiense
by: Ammar Usman Danazumi, et al.
Published: (2022-01-01)

Prostate-based biofluids for the detection of prostate cancer: A comparative study of the diagnostic performance of cell-sourced RNA biomarkers
by: Matthew J. Roberts, et al.
Published: (2016-09-01)

Prostate cancer biomarkers: Are we hitting the mark?
by: Shannon McGrath, et al.
Published: (2016-12-01)

Single-lesion Prostate-specific Membrane Antigen Protein Expression (PSMA) and Response to [177Lu]-PSMA-ligand Therapy in Patients with Castration-resistant Prostate Cancer
by: Judith Stangl-Kremser, et al.
Published: (2021-08-01)

TMEM106A transcriptionally regulated by promoter methylation is involved in invasion and metastasis of hepatocellular carcinoma
by: Shi Shiming, et al.
Published: (2022-06-01)

A RARE CASE OF ISOLATED SOLITARY PULMONARY METASTASIS OF PROSTATE CARCINOMA
by: Işıl Çetin, et al.
Published: (2025-06-01)

STEAP3 is a potential preliminary prognostic biomarker of glioblastoma
by: Wenhua Zhang, et al.
Published: (2024-12-01)

Usefulness of prostate specific antigen density in detecting prostate carcinoma: A hospital-based study in patients with prostate biopsies
by: Reshmi Shrestha, et al.
Published: (2022-03-01)

Prostate-specific antigen 10–20 ng/mL: A predictor of degree of upgrading to ≥8 among patients with biopsy Gleason score 6
by: Glen Denmer R. Santok, et al.
Published: (2017-03-01)

Clinical application of free/total PSA ratio in the diagnosis of prostate cancer in men over 50 years of age with total PSA levels of 2.0–25.0 ng ml-1 in Western China
by: Xue-Dan Gao, et al.
Published: (2022-01-01)

Association of Serum PSA, fPSA, and CEA Levels with Prognosis and Clinicopathological Characteristics in Prostate Cancer
by: Ahamed Y, et al.
Published: (2025-08-01)

Percent free prostate-specific antigen is effective to predict prostate biopsy outcome in Chinese men with prostate-specific antigen between 10.1 and 20.0 ng ml−1
by: Rui Chen, et al.
Published: (2015-01-01)

Prostate-specific antigen and prostate-specific antigen density cutoff points among Indonesian population suspected for prostate cancer
by: Ahmad Anies Shahab, et al.
Published: (2013-03-01)

Prognostic Role of PSMA-Targeted Imaging in Metastatic Castration-Resistant Prostate Cancer: An Overview
by: Matteo Caracciolo, et al.
Published: (2024-10-01)

Toxins secreted by Bacillus isolated from lung adenocarcinomas favor the penetration of toxic substances
by: Alexandra eMerlos, et al.
Published: (2015-11-01)

THE PROGNOSTIC VALUE OF BASELINE PSA BLOOD IN THE TREATMENT OF PROSTATE CANCER
by: A. A. Gritskevich, et al.
Published: (2017-02-01)

Prospective validation study of a combined urine and plasma test for predicting high-grade prostate cancer in biopsy naïve men
by: Torben Brøchner Pedersen, et al.
Published: (2025-01-01)

Interassay Variability and Clinical Implications of Five Different Prostate-specific Antigen Assays
by: Basil Kaufmann, et al.
Published: (2024-05-01)

BIOMARKERS FOR DIAGNOSING OF PROSTATE CANCER: THE PRESENT AND THE FUTURE
by: L. M. Rapoport, et al.
Published: (2018-05-01)

Sphingomyelinase decreases transepithelial anion secretion in airway epithelial cells in part by inhibiting CFTR‐mediated apical conductance
by: Kirsten A. Cottrill, et al.
Published: (2021-08-01)

Transmembrane protein 88 suppresses hepatocellular carcinoma progression and serves as a novel prognostic factor
by: Lin Cai, et al.
Published: (2023-04-01)

The diagnostic value of a new formula combining age and prostate volume in prostate cancer
by: Xiaobo Yang, et al.
Published: (2022-02-01)

Use of classical and novel biomarkers as prognostic risk factors for localised prostate cancer: a systematic review
by: P Sutcliffe, et al.
Published: (2009-01-01)

Effect of Temperature and Humidity on Serum Prostate Specific Antigen Levels in Asymptomatic Male Population
by: Murat Tuğrul Eren, et al.
Published: (2016-12-01)

Trends of clinical symptoms and prognosis of middle-aged prostate cancer patients after instigation of prostate specific antigen-based population screening
by: Yasuhide Kitagawa, et al.
Published: (2013-06-01)

Decreased levels of cathepsin Z mRNA expressed by immune blood cells: diagnostic and prognostic implications in prostate cancer
by: A.A.S. Batista, et al.
Published: (2021-08-01)

Review of Clinical Manifestations of Biochemically-advanced Prostate Cancer Cases
by: Edmund Chiong, et al.
Published: (2005-07-01)

Epidemiological Study of Patients with Prostate Cancer in South of Iraq
by: Manal Badi Salih Al-Tmemi
Published: (2019-07-01)